Approved comparison material connected to this topic.
3 total recordsSource comparisons are presented without a generated winner.
J Clin Endocrinol Metab 2020 (healthy males, n=42) 100mcg 3×/day subcutaneous Mild injection-site erythema (12%), transient facial flushing (8%) +14% vs baseline (non-cumulative) 8 weeks Transient GH pulse wit…
| Compound | Half-Life | Dosing Frequency | Longest Published Human Study | Known Long-Term Risks | Receptor Desensitization Evidence | Professional Assessment ||—|—|—|—|—|—|| CJC-1295 no DAC (modified GRF 1-2…
CJC-1295 no DAC GHRH receptor agonist <30 minutes (peptide), 2–3 hour GH pulse Injection-site reactions (22%), headaches (18%), flushing (12%) Low. Transient hypoglycaemia risk in glucose-impaired subjects Bes…